Prospective Antitumor Effects of the Combination of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) and Cisplatin Against Esophageal Squamous Cell Carcinoma
Author:
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Surgery
Link
http://link.springer.com/content/pdf/10.1007/s00595-006-3295-5.pdf
Reference35 articles.
1. Usefulness of preoperative low dose cisplatin treatment for advanced esophageal cancer
2. Identification and characterization of a new member of the TNF family that induces apoptosis
3. Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
4. The Receptor for the Cytotoxic Ligand TRAIL
5. Characterization of two receptors for TRAIL1
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Herb-drug interaction: A case study of effects and involved mechanisms of cisplatin on the pharmacokinetics of ginsenoside Rb1 in tumor-bearing mice;Biomedicine & Pharmacotherapy;2019-02
2. Human Embryonic Stem Cells Acquire Responsiveness to TRAIL upon Exposure to Cisplatin;Stem Cells International;2019-01-21
3. New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants;Drug Resistance Updates;2015-05
4. Esophageal cancer-selective expression of TRAIL mediated by MREs of miR-143 and miR-122;Tumor Biology;2014-03-22
5. Apoptotic Efect of CGM co-treatment with Cisplatin on G361 Human Melanoma Cell Line;The Korean Journal of Oral Anatomy;2013-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3